-
Lilly weight loss pills are crazily chasing after semaglutide
On August 8th, Eli Lilly released its second quarter financial report, achieving global revenue of $11.3028 billion, a year-on-year increase of 36%; The total revenue for the first half of the year w ... -
Oral "weight loss medication" further advances Novo Nordisk oral semaglutide weight loss phase III research success
Reporter Chen Xing On August 7th, Novo Nordisk announced its H1 2024 results that the Phase III OASIS 4 study on weight loss with oral semaglutide Rybelsus (25mg) has been successfully completed. Ora ... -
"Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
On June 27th, it was reported in the market that the "weight loss miracle drug" Wegovy (Chinese product name: Nuoheying) will be sold in limited quantities in China. On June 28th, relevant personnel ... -
Earning too much! US Senators indirectly pressure Novo Nordisk to lower the price of weight loss pills
On Monday local time, US Senator Bernie Sanders wrote a letter to Politburo, one of the largest newspapers in Nordic countries, urging Denmark to pressure the well-known pharmaceutical company Novo N ... -
American pharmaceutical company Anjin's weight loss pills have attracted attention, and Novo Nordisk's stock price has fallen by 5%
American pharmaceutical company Anjin Weight Loss Medicine has attracted attention, with Novo Nordisk's stock price falling 5%. -
Novo Nordisk promises to invest $6 billion to expand production capacity. Prices of weight loss drugs in the United States are expected to further decrease
On Thursday, weight loss drug giant Novo Nordisk held a earnings conference call, promising to further adopt a price reduction strategy in the US market. The company's Chief Financial Officer, Karste ... -
GLP-1 Weight Loss Drug Production Capacity Warming Up: Lilly builds a factory in Germany for $2.5 billion and is expected to operate in 2027
The GLP-1 weight loss drug, which is in a race for development, is also highly competitive in terms of production capacity. Recently, Lilly held a groundbreaking ceremony for a new factory in Frankfu ... -
Has the "Seven Technology Giants" fallen out of favor? Xiaomo: Retail investors are turning to weight loss drug manufacturers such as Lilly
JPMorgan said in its latest report on Wednesday that retail investors sold most of the stocks in the "tech seven" last week, with the focus shifting to pharmaceutical companies such as Eli Lilly. Acc ... -
Are you optimistic about AI and weight loss pills? Qiaoshui Q4 significantly increases holdings of NVIDIA and Lilly
On Wednesday (February 14) Eastern Time, well-known hedge fund Bridgewater submitted its US stock holdings report (13F) as of the end of the fourth quarter of last year to the Securities and Exchange ... -
Novo Nordisk invests billions of dollars to buy factories and launches a battle for weight loss drug production capacity
Global weight loss drug leader Novo Nordisk has made new moves in expanding production. On February 5th, Novo Nordisk announced that its controlling shareholder Novo Holdings had agreed to acquire CD ... -
Weight loss drug giant Novo Nordisk's new move invests $11 billion to acquire a factory
Novo Nordisk announced a $11 billion acquisition of three production factories to meet the growing demand for weight loss drugs. On January 31st, Novo Nordisk released its 2023 results, with a total ... -
Over 1.8 billion yuan invested in the introduction of oral weight loss drugs, Novo Nordisk, to accelerate horse racing and compete in the weight loss market, upgrading the competition
Entering 2024, the track of weight loss pills remains hot. On January 23rd local time, Danish pharmaceutical giant Novo Nordisk and Swiss biotechnology company EraCal Therapeutics (hereinafter referr ... -
Weight loss pills will bring benefits again! FDA assessment: Wegovy and other drugs are not associated with suicidal thoughts
The latest discovery by US regulatory agencies that GLP-1 weight loss drugs such as Wegovy under Novo Nordisk are not associated with suicidal thoughts is a positive signal for these popular drugs an ... -
The pharmaceutical landscape is completely overturned by 2023: in addition to weight loss drugs and hot money, they are also pouring into these fields
Throughout this year, major international pharmaceutical companies have made breakthroughs in multiple fields, which have not only benefited humanity but also changed the industry's landscape in the ... -
Apple burst! Take down and stop selling! What happened? 3 trillion yuan giant's emergency crackdown on counterfeits is related to "weight loss pills"
Apple's sudden bearish news. On December 18th local time, Apple announced that starting from 3pm local time on December 21st, the official website of Apple in the United States will stop selling the ... -
Fake weight loss pills are rampant! Novo Nordisk is teaming up with Indian e-commerce platforms to vigorously curb illegal sales
According to a source, Novo Nordisk's legal team in India is collaborating with India's online e-commerce platform IndiaMART to develop a framework to remove counterfeit weight loss drugs from the pl ... -
Overseas celebrity fund managers share next year's investment experience: Don't trust technology stocks, still be optimistic about weight loss pills!
An overseas star fund manager who outperformed 97% of his peers in performance this year shared his vision of next year's "investment experience" this week. One of the biggest highlights in his outlo ... -
Lilly's weight loss pills were accused of rebounding after discontinuation, and the company's stock price plummeted at one point
According to the Red Star Capital Bureau, the stock price of weight loss drug giant LY. US fell at the beginning of trading on December 11th local time, with a drop of over 5% during the trading sess ... -
Another pharmaceutical giant has entered the weight loss drug market! The GLP-1 track of the US stock market is once again hotly speculated
On Monday Eastern Time, Swiss pharmaceutical giant Roche announced its entry into the weight loss drug market through acquisition, challenging weight loss drug giants Novo Nordisk and Lilly. After th ... -
Pfizer's failed development of oral weight loss drugs has no hope of turning around in the short term
The best performing companies in the healthcare sector this year have all benefited from the weight loss drug boom. Pfizer also hopes to make a comeback with an oral weight loss drug, but the latest ...